XTalks

APRIL 26, 2023

Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Poster Presentation, Innovations in Dermatology Conference, Las Vegas, NV, November 3-5, 2022. Dermatology. Dermatology. References Merry SP, Croghan I, McCormick B, Chatha K, Leffell D. Three-point checklist of dermoscopy. 2004;208:27-31.

Life Science 52

Life Science Dermatology Clinical Trials Clinical Trials 52

pharmaphorum

NOVEMBER 9, 2021

In this report, we speak to key opinion leaders and biopharmaceutical executives to reveal insights on the market landscape and explore novel opportunities for life science companies to become valued partners for stakeholders they serve. These challenges often prevent them from prescribing novel treatments to patients.

Life Science 52

Life Science Marketing Development Research 52

Pharmaceutical Technology

MAY 8, 2023

It offers drugs spanning therapeutic areas such as respiratory, oncology, immuno-inflammation, central nervous system (CNS), metabolic, cardiovascular, dermatology, bacterial infections, viral infections, including HIV, and rare diseases.

Antibody 246

Antibody Vaccine Vaccination Dermatology 246

XTalks

MAY 25, 2023

Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Filler 52

Filler Life Science FDA Approval Drugs 52

XTalks

AUGUST 14, 2024

In a press release video , Shawn Kwatra, MD, professor and chair of dermatology in the Department of Dermatology at the University of Maryland School of Medicine, explained that IL-31 is often referred to as the “master itch cytokine.”

Drug Delivery Systems 111

Drug Delivery Systems Dermatology Drug Delivery Antibody 111

XTalks

APRIL 17, 2023

These results are very promising for patients with atopic dermatitis,” said Jonathan Silverberg, MD, professor of dermatology at George Washington University School of Medicine & Health Sciences and co-investigator of the studies, in the company’s press release.

Dermatology 97

Dermatology Antibody Clinical Trials Clinical Trials 97

XTalks

MAY 23, 2024

For healthcare and life sciences industries, Skin Cancer Awareness Month helps highlight the importance of preventive measures and early detection. Companies specializing in dermatology and skincare have developed a range of products aimed at protecting the skin from harmful UV rays.

Life Science 72

Life Science Dermatology Drug Delivery Systems Medicine 72

XTalks

SEPTEMBER 30, 2024

Presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, the study highlighted significant improvements in key disease markers, positioning orismilast as a potential breakthrough in atopic dermatitis management.

Clinical Trials 98

Clinical Trials Clinical Trials Dermatology Trials 98

XTalks

JUNE 20, 2022

The results of their Phase IIa STP705 clinical study were published in the Journal of Drugs in Dermatology , a peer-reviewed medical journal of dermatology that was established in 2002. STP705 — A Promising siRNA Candidate Against isSCC. STP705 is comprised of two siRNA oligonucleotides targeting TGF-?

RNA 96

RNA Clinical Trials Clinical Trials Dermatology 96

XTalks

MARCH 24, 2023

The company recently presented a pooled analysis from clinical studies of their DermaSensor skin cancer detection device at the American Academy of Dermatology (AAD) 2023 Annual Meeting. DermaSensor is a health-technology company focused on developing non-invasive tools to better equip primary care physicians for skin cancer detection.

Dermatology 97

Dermatology Clinical Trials Clinical Trials Sales 97

Pharmaceutical Technology

MAY 8, 2023

It offers drugs spanning therapeutic areas such as respiratory, oncology, immuno-inflammation, central nervous system (CNS), metabolic, cardiovascular, dermatology, bacterial infections, viral infections, including HIV, and rare diseases.

Antibody 147

Antibody Vaccine Vaccination Dermatology 147

XTalks

JUNE 26, 2024

Hyperhidrosis is the third most prevalent dermatological condition in the US, affecting roughly 15.3 The Impact of Hyperhidrosis on Quality of Life Hyperhidrosis has profound effects on mental health , self-esteem, social interactions, relationships and occupational choices. million people, following acne and atopic dermatitis.

Clinical Trials 103

Clinical Trials Clinical Trials Dermatology FDA Approval 103

XTalks

MAY 22, 2023

It’s an extremely important factor I consider in my therapeutic process of restoring their natural beauty and appearance,” said Macrene Alexiades, MD, PhD, dual US-EU board-certified dermatologist, SkinVive by Juvéderm lead investigator and author of the clinical trial published in Dermatologic Surgery.

Filler 92

Filler FDA Approval Dermatology In-Vivo 92

XTalks

MAY 26, 2023

Peter Marinkovich, primary investigator of the GEM-3 trial, director of the Blistering Disease Clinic at Stanford Health Care and associate professor of dermatology at the Stanford University School of Medicine. Related: Hemgenix Approved as First Gene Therapy for Hemophilia B “This is a devastating disease,” said M.

Gene Therapy 97

Gene Therapy Gene FDA Approval Dermatology 97

XTalks

JULY 31, 2024

“An oral JAK that delivers proven results will be impactful for the alopecia areata community,” added Dr. Natasha Mesinkovska, associate professor and vice chair for Clinical Research of Dermatology, University of California, Irvine and investigator in the Leqselvi clinical development program.

Immune Response 105

Immune Response Dermatology Clinical Trials Clinical Trials 105

XTalks

MARCH 18, 2025

Hidradenitis suppurativa affecting roughly 1% of the population is a chronic skin condition marked by painful boils and abscesses that can significantly disrupt daily life.

Trials 59

Trials Clinical Trials Clinical Trials Hormones 59

XTalks

AUGUST 7, 2023

Verrica, a company specializing in dermatology therapeutics, has designed Ycanth to be delivered through a single-use applicator. Ycanth (cantharidin) topical solution, developed by Verrica Pharmaceuticals Inc., Formerly known as VP-102, Ycanth is the first cantharidin formulation approved for this purpose.

FDA Approval 98

FDA Approval Dermatology Trials Clinical Trials 98

XTalks

DECEMBER 15, 2020

Synteract has a solid reputation in the emerging biopharma sphere, providing therapeutic expertise in areas including oncology, rare and orphan diseases, neuroscience, dermatology and pediatrics. Syneos itself arose out of a $7.4 billion between INC Research and inVentiv three years ago, rebranding as Syneos Health.

Dermatology 98

Dermatology Clinical Trials Clinical Trials Branding 98

pharmaphorum

DECEMBER 9, 2021

We are combining our life-science expertise and ingenuity to leverage digital technologies to accelerate innovation, applying a digital first mindset to how we innovate by using data to analyse and predict what our consumers need.”. “We Self care, skin health and technology innovation.

Allergies 105

Allergies Life Science Development Scientist 105

XTalks

MARCH 6, 2023

Their areas of focus include gastrointestinal and cardiovascular systems, oncology, pain management, dermatology, and diabetes, with large markets in the United States, India, Russia, China, Brazil, and Europe. The company offers numerous products including generics, branded generics, biosimilars and over-the-counter products.

Production 98

Production Branding Dermatology Hormones 98

The Pharma Data

JANUARY 12, 2021

13, 2021 (GLOBE NEWSWIRE) — Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces the appointment of Dr Neil Graham MBBS, MD, MPH as Chief Medical Officer.

Life Science 52

Life Science Antibody In-Vivo In-Vitro 52

XTalks

MAY 31, 2023

Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Gene Therapy 52

Gene Therapy Gene FDA Approval Life Science 52

XTalks

JULY 16, 2021

Related: Google Launches AI-Based Dermatology Assist Tool. Nevertheless, J&J has advised customers to discontinue use and throw out any of the products affected by the benzene contamination, which include the Neutrogena spray brands Beach Defense, Cool Dry Sport, Invisible Daily and Ultra Sheer; and Aveeno Protect + Refresh.

Contamination 105

Contamination Production Drugs Branding 105

XTalks

JUNE 10, 2021

Related: Google Launches AI-Based Dermatology Assist Tool. As such, they say digital devices integrated into fibers could lead to fabrics with digital system capabilities for applications in physiological monitoring, human-computer interfaces and on-body machine-learning.

Research 111

Research Development Containment Engineer 111

pharmaphorum

JULY 8, 2022

Thread is helping customers create and utilise digital endpoints in therapeutic areas like dermatology, respiratory, and CNS applications where the voice data capture is becoming important. Dr Steven LeBoeuf , founder, Valencell, US, a market leader in the innovative science of wearable biometric devices that deliver enhanced health results.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Regulation 100

XTalks

MAY 31, 2022

At Dermavant, we are committed to advancing novel, patient-focused innovation in immuno-dermatology.

FDA Approval 98

FDA Approval Clinical Trials Clinical Trials Trials 98

XTalks

MARCH 10, 2022

Last year, Penn’s medical school apologized for Kligman’s testing and renamed his dermatology professorship after a Black colleague. Penn Medicine apologizes for the pain Dr. Kligman’s work caused to incarcerated individuals, their families and our broader community,” Penn’s medical school dean, J.

Containment 98

Containment Dermatology Contamination Sales 98

Pharma in Brief

JANUARY 15, 2024

2,478,237 (the 237 Patent ), which relates to the use of adapalene to treat dermatological disorders. concentration of adapalene for the treatment of dermatological disorders. The FC concluded that the Board’s decision was reasonable. Background This case concerns Canadian Patent No. The patentee, Galderma Canada Inc.

Dermatology 52

Dermatology Medicine Production Containment 52

XTalks

SEPTEMBER 22, 2022

Waldman Department of Dermatology. Longer trials are needed to fully understand the effects and safety of Spevigo in those affected by GPP using the treatment long-term.

FDA Approval 52

FDA Approval Clinical Trials Clinical Trials Dermatology 52

XTalks

MAY 19, 2023

Clinical Trials by Therapeutic Area The top ten therapy areas from 2017 to 2022 ranked by the number of clinical trials worldwide are: Oncology (24 percent) Infectious disease (12 percent) Neurology (ten percent) Hematology (eight percent) Endocrinology (six percent) Respiratory (five percent) Dermatology (five percent) Cardiovascular (four percent) (..)

Clinical Trials 97

Clinical Trials Clinical Trials Trials Clinical Research 97

XTalks

JANUARY 2, 2024

Chiesi Global Rare Diseases, a specialized division within the Chiesi Group dedicated to pioneering therapies for individuals affected by rare diseases, has received approval from the US Food and Drug Administration (FDA) for Filsuvez (birch triterpenes) topical gel.

FDA Approval 111

FDA Approval Gene Therapy Gene Trials 111

XTalks

AUGUST 2, 2023

With Blackstone Life Sciences, up to €300 million (around $315 million USD) will be invested to accelerate pivotal studies and clinical development programs for formulating the subcutaneous delivery of the anti-CD38 antibody Sarclisa (isatuximab) for the treatment of multiple myeloma. 21) Merck KGaA By: Ayesha Rashid, Ph.D.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

JUNE 17, 2024

RELATED: Innovations and Clinical Trial Diversity in Medical Aesthetics: Insights from Dr. Stephanie Manson Brown, VP & Head of Clinical Development at Allergan Aesthetics – Xtalks Life Science Podcast Ep. 134 How Does Letybo Work? Letybo is classified as an acetylcholine release inhibitor and neuromuscular blocking agent.

FDA Approval 52

FDA Approval Marketing Botox Clinical Trials 52

XTalks

JUNE 10, 2024

When psoriasis gets really bad, it’s really hard to get up again,” shared popstar Cindy Lauper in an interview with the American Academy of Dermatology Association. It is a sentiment that heavily resonates within the psoriasis community. More About Psoriasis About 7.55

Immune Response 52

Immune Response Dermatology Clinical Trials Clinical Trials 52

XTalks

NOVEMBER 2, 2023

The biosimilar to Johnson & Johnson’s Stelara is approved for use by adults for the listed indications, as well as pediatric patients six years of age and older for the dermatologic indications (plaque psoriasis and psoriatic arthritis).

FDA Approval 59

FDA Approval Production Dermatology Sales 59

XTalks

DECEMBER 15, 2020

Synteract has a solid reputation in the emerging biopharma sphere, providing therapeutic expertise in areas including oncology, rare and orphan diseases, neuroscience, dermatology and pediatrics. Syneos itself arose out of a $7.4 billion between INC Research and inVentiv three years ago, rebranding as Syneos Health.

Dermatology 52

Dermatology Clinical Trials Clinical Trials Branding 52

Pharma in Brief

JULY 7, 2020

2,478,237 (the 237 Patent ), which relates to the use of adapalene to treat dermatological disorders. concentration of adapalene for the treatment of dermatological disorders. Background. This case concerns Canadian Patent No. The patentee, Galderma Canada Inc. adapalene ( DIFFERIN ).

Medicine 40

Medicine Dermatology Containment Production 40